OrthoPediatrics Corp.

NasdaqGM KIDS

OrthoPediatrics Corp. Price to Sales Ratio (P/S) on January 14, 2025: 3.01

OrthoPediatrics Corp. Price to Sales Ratio (P/S) is 3.01 on January 14, 2025, a -34.55% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

OrthoPediatrics Corp. 52-week high Price to Sales Ratio (P/S) is 5.11 on May 07, 2024, which is 70.09% above the current Price to Sales Ratio (P/S).
OrthoPediatrics Corp. 52-week low Price to Sales Ratio (P/S) is 2.80 on December 12, 2024, which is -6.92% below the current Price to Sales Ratio (P/S).
OrthoPediatrics Corp. average Price to Sales Ratio (P/S) for the last 52 weeks is 4.02.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NasdaqGM: KIDS

OrthoPediatrics Corp.

CEO	Mr. David R. Bailey
IPO Date	Oct. 13, 2017
Location	United States
Headquarters	2850 Frontier Drive
Employees	247
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Key trends

Past 5 years